Venous Thromboembolism - Pipeline Insight, 2019 - ResearchAndMarkets.com

The "Venous Thromboembolism - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.

Metadata

Provider:

Business Wire, Inc.

Retrieved on:

Monday, February 4, 2019

Information

Tags:

Health, Cardiology, Pharmaceutical, Pipeline, Drug pipeline

⚠generated by AI ↴

Summary

Key Points:

The "Venous Thromboembolism - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
This report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Venous Thromboembolism development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
The report covers pipeline activity across the complete product development cycle i.e.

The "Venous
Thromboembolism - Pipeline Insight, 2019" drug pipelines has
been added to ResearchAndMarkets.com's offering.

This report offers comprehensive insights of the pipeline (under
development) therapeutics scenario and growth prospects across Venous
Thromboembolism development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental
Stages:

Clinical
Non-clinical
Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product
profiles including (but not limited to) drug description, product
development and R&D activities encompassing clinical and pre-clinical
studies, designations, collaborations, licensing deals, grants,
technologies and patent details.

Scope of the Report

The report provides a snapshot of the pipeline development for the
Venous Thromboembolism
The report covers pipeline activity across the complete product
development cycle i.e. clinical, pre-clinical and discovery stages for
the Venous Thromboembolism
The report provides pipeline product profiles which includes product
description, developmental activities, licensors & collaborators and
chemical information
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development, route of administration, and molecule
type for Venous Thromboembolism
The report also covers the dormant and discontinued pipeline projects
related to Venous Thromboembolism

Reasons to Buy

Establish comprehensive understanding of the pipeline activity across
this Venous Thromboembolism to formulate effective R&D strategies
Gather information of the emerging competitors having potentially
lucrative portfolio in this space and create effective counter
strategies to gain competitive advantage
Identify the relationship between the drugs and use it for target
finding, drug repurposing, and precision medicine
Plot corrective measures for pipeline projects by understanding the
pipeline depth and focus of Venous Thromboembolism therapeutics
Devise in licensing and out licensing strategies by identifying
prospective partners with the most attractive projects to enhance and
expand business potential and scope
Modify the therapeutic portfolio by identifying inactive projects and
understanding the factors that might have halted their progress